Header Logo

Connection

MEGHANA TRIVEDI to Disease Progression

Back to Details
This is a "connection" page, showing publications MEGHANA TRIVEDI has written about Disease Progression.
MEGHANA TRIVEDI
Connection Strength
0.044
Disease Progression
  1. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother. 2019 05; 53(5):501-509.
    View in: PubMed
    Score: 0.026
  2. Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res. 2013 Dec 01; 19(23):6389-97.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.